Clinical Trial Update: ToPanc Trial: Survival After Total Versus Partial Pancreaticoduodenectomy for Adenocarcinoma of the Pancreatic Head, Distal Cholangiocarcinoma, and Ampullary Cancer [NA]

View source ↗

Summary

The ToPanc trial is evaluating survival after total versus partial pancreaticoduodenectomy for pancreatic head adenocarcinoma, distal cholangiocarcinoma, and am…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ampullary Cancer
• Distal Cholangiocarcinoma
• Pancreatic Cancer

Snippet

Sponsor: Insel Gruppe AG, University Hospital Bern | Conditions: Pancreatic Cancer | NA | Status: RECRUITING